IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0110877
(2008-04-28)
|
등록번호 |
US-8778348
(2014-07-15)
|
발명자
/ 주소 |
- Knapp, Elisabeth
- Yusibov, Vidadi
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
4 인용 특허 :
78 |
초록
▼
The present invention relates to the intersection of the fields of immunology and protein engineering, and particularly to antigens and vaccines useful in prevention of infection by Trypanosoma protozoa. Provided are recombinant protein antigens, compositions, and methods for the production and use
The present invention relates to the intersection of the fields of immunology and protein engineering, and particularly to antigens and vaccines useful in prevention of infection by Trypanosoma protozoa. Provided are recombinant protein antigens, compositions, and methods for the production and use of such antigens and vaccine compositions.
대표청구항
▼
1. An isolated antigen comprising a component of a Trypanosoma protein fused to alfalfa mosaic virus (AlMV) coat protein; wherein the Trypanosoma protein component is a fragment of alpha tubulin or a fragment of beta tubulin consisting of one or more amino acid sequences selected from the group cons
1. An isolated antigen comprising a component of a Trypanosoma protein fused to alfalfa mosaic virus (AlMV) coat protein; wherein the Trypanosoma protein component is a fragment of alpha tubulin or a fragment of beta tubulin consisting of one or more amino acid sequences selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 2. The isolated antigen of claim 1, wherein the Trypanosoma protein component is a polytope. 3. The isolated antigen of claim 1, wherein the Trypanosoma protein component consists of at least two sequences selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 4. The isolated antigen of claim 3, wherein the Trypanosoma protein component consists of a portion of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11 and a portion of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20, a plurality of portions of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11, ora plurality of portions of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 5. A composition comprising a pharmaceutically acceptable carrier and a first antigen comprising a component of a Trypanosoma protein fused to AlMV coat protein; wherein the Trypanosoma protein component is a fragment of alpha tubulin or a fragment of beta tubulin consisting of one or more amino acid sequences selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20; andwherein the composition is capable of eliciting an immune response upon administration to a subject. 6. The composition of claim 5, wherein the Trypanosoma protein component consists of at least two domains selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 7. The composition of claim 6, wherein the Trypanosoma protein component consists of at least one portion of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11 and at least one portion of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20, a plurality of portions of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11, ora plurality of portions of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 8. The composition of claim 5, further comprising a second antigen, wherein the second antigen comprises a component of a Trypanosoma protein fused to a thermostable protein or fused to AlMV coat protein, wherein the Trypanosoma protein component of the second antigen is distinct from the first antigen and is selected from the group consisting of a fragment of alpha tubulin having the sequence set forth in SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, or SEQ ID NO:11 and a fragment of beta tubulin having the sequence set forth in SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, or SEQ ID NO:20; andwherein the composition is capable of eliciting an immune response upon administration to a subject. 9. The composition of claim 5, wherein the antigen is produced in a plant selected from a transgenic plant and a plant transiently expressing the antigen. 10. The composition of claim 5, wherein the composition comprises antigen which is purified, partially purified, or unpurified from plant cells, a plant, seeds, fruit, or an extract thereof. 11. A composition comprising at least two antigens, each of which comprises a component of a Trypanosoma protein, wherein the Trypanosoma protein components each consist of an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20; wherein at least one of the antigens is fused to AlMV coat protein;wherein the composition comprises a pharmaceutically acceptable carrier; andwherein the composition is capable of eliciting an immune response upon administration to a subject. 12. A method for inducing an immune response against Trypanosoma infection in a subject comprising administering to a subject an effective amount of an anti-Trypanosoma composition, wherein the administration is sufficient to stimulate production of antigen specific antibodies or stimulate a cellular immune response by the subject; thereby inducing an immune response; wherein the composition comprises an antigen comprising a component of a Trypanosoma protein fused to AlMV coat protein; andwherein the Trypanosoma protein component is a fragment of alpha tubulin or a fragment of beta tubulin consisting of one or more amino acid sequences selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 13. An isolated antigen comprising a component of a Trypanosoma protein fused to a thermostable protein; wherein the Trypanosoma protein component is a fragment of alpha tubulin or a fragment of beta tubulin consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 14. The isolated antigen of claim 13, wherein the Trypanosoma protein component is a polytope. 15. The isolated antigen of claim 13, wherein the Trypanosoma protein component consists of at least two sequences selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 16. The isolated antigen of claim 15, wherein the Trypanosoma protein component consists of a portion of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11 and a portion of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20, a plurality of portions of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11, ora plurality of portions of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 17. A composition comprising a pharmaceutically acceptable carrier and a first antigen comprising a component of a Trypanosoma protein fused to a thermostable protein; wherein the Trypanosoma protein component consists of one or more fragments of alpha tubulin or beta tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20; andwherein the composition is capable of eliciting an immune response upon administration to a subject. 18. The composition of claim 17, wherein the Trypanosoma protein component consists of at least two domains selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 19. The composition of claim 18, wherein the Trypanosoma protein component consists of at least one portion of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11 and at least one portion of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20, a plurality of portions of alpha tubulin selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11, ora plurality of portions of beta tubulin selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20. 20. The composition of claim 17, further comprising a second antigen, wherein the second antigen comprises a component of a Trypanosoma protein fused to a thermostable protein or fused to AlMV coat protein and a pharmaceutically acceptable carrier; wherein the Trypanosoma protein component of the second antigen is distinct from the first antigen and is selected from the group consisting of a fragment of alpha tubulin having the sequence set forth in SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, or SEQ ID NO:11 and a fragment of beta tubulin having the sequence set forth in SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, or SEQ ID NO:20; andwherein the composition is capable of eliciting an immune response upon administration to a subject. 21. The composition of claim 17, wherein the antigen is produced in a plant selected from a transgenic plant and a plant transiently expressing the antigen. 22. The composition of claim 17, wherein the composition comprises antigen which is purified, partially purified, or unpurified from plant cells, a plant, seeds, fruit, or an extract thereof. 23. A method for inducing an immune response against Trypanosoma infection in a subject comprising administering to a subject an effective amount of an anti-Trypanosoma composition, wherein the administration is sufficient to stimulate production of antigen specific antibodies or stimulate a cellular immune response by the subject; thereby inducing an immune response; wherein the composition comprises an antigen comprising a component of a Trypanosoma protein fused to a thermostable protein; andwherein the Trypanosoma protein component is a fragment of alpha tubulin or a fragment of beta tubulin consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:19, and SEQ ID NO:20.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.